Opinion|Videos|August 12, 2024
Navigating Access Challenges in CLL Treatment: Strategies for Overcoming Barriers
A panel of experts discuss navigating access challenges in CLL treatment.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- What are the major access challenges in CLL treatment, and how can they be overcome?
- How do payer policies and clinical pathways affect the clinical decision-making process for CLL treatments?
Advertisement
Related to this article
Even when physicians prescribe guideline-preferred therapies, step therapy and prior authorization can delay or restrict access to CLL therapies.
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
3
5 Things to Know if Retatrutide Is Classified as a Biologic
4
NEI Director Highlights Pediatric Advances, AI’s Promise in Eye Care
5